A live webcast of Infinity's presentation will be accessible on the
“investors/media” section of the company's website, www.infi.com,
and will be available for 30 days following the event.

About Infinity Pharmaceuticals, Inc.Infinity is an
innovative drug discovery and development company seeking to discover,
develop and deliver to patients best-in-class medicines for diseases
with significant unmet need. Infinity combines proven scientific
expertise with a passion for developing novel small molecule drugs that
target emerging disease pathways. Infinity's programs focused on the
inhibition of phosphoinositide-3-kinase and heat shock protein 90 are
evidence of its innovative approach to drug discovery and development.
For more information on Infinity, please refer to the company's website
at www.infi.com.

Restrictions

All rights reserved. Republication or redistribution of Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. Thomson Reuters is not liable for any errors or delays in Thomson Reuters content, or for any actions taken in reliance on such content. ‘Thomson Reuters’ and the Thomson Reuters logo are trademarks of Thomson Reuters and its affiliated companies.